2005
DOI: 10.1016/j.clinmicnews.2005.04.002
|View full text |Cite
|
Sign up to set email alerts
|

Fatal community-acquired Brevundimonas vesicularis bacteremia in an elderly patient

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
1

Year Published

2012
2012
2018
2018

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 13 publications
0
2
1
Order By: Relevance
“…According to a study from the Centers for Disease Control and Prevention, B. vesicularis is highly susceptible to all aminoglycosides (98 %), piperacillin (100 %), carbenicillin (94 %) and ceftizoxime (94 %), with moderate susceptibility to cefamandole (50 %) and cefoxitin (75 %), and lower susceptibility to penicillin (12 %) and ampicillin (22 %) (Clark et al, 1984). However, a wide variation of susceptibility to antimicrobial agents has been described in previous reports (Planes et al, 1992;Gilad et al, 2000;Oberhelman et al, 1994;Chi et al, 2004;Papaefstathiou et al, 2005;Choi et al, 2006;Yang et al, 2006;Kwak et al, 2009;Vahid, 2006;Mondello et al, 2006;Pelletier et al, 2010;Bhatawadekar & Sharma, 2011;Chandra et al, 2010). In our study, there was a discrepancy between the two measures of susceptibility to imipenem.…”
Section: Liver Abscess Caused By Brevundimonas Vesiculariscontrasting
confidence: 53%
“…According to a study from the Centers for Disease Control and Prevention, B. vesicularis is highly susceptible to all aminoglycosides (98 %), piperacillin (100 %), carbenicillin (94 %) and ceftizoxime (94 %), with moderate susceptibility to cefamandole (50 %) and cefoxitin (75 %), and lower susceptibility to penicillin (12 %) and ampicillin (22 %) (Clark et al, 1984). However, a wide variation of susceptibility to antimicrobial agents has been described in previous reports (Planes et al, 1992;Gilad et al, 2000;Oberhelman et al, 1994;Chi et al, 2004;Papaefstathiou et al, 2005;Choi et al, 2006;Yang et al, 2006;Kwak et al, 2009;Vahid, 2006;Mondello et al, 2006;Pelletier et al, 2010;Bhatawadekar & Sharma, 2011;Chandra et al, 2010). In our study, there was a discrepancy between the two measures of susceptibility to imipenem.…”
Section: Liver Abscess Caused By Brevundimonas Vesiculariscontrasting
confidence: 53%
“…; the authors admitted, that CLSI outlines are sometimes neglected in the literature. Strains as Brevundimonas vesicularis might contribute to fatal infections [25,26], so the disc diffusion method outlines need to be broaden.…”
Section: Discussionmentioning
confidence: 99%
“…[ 63 ], B. diminuta 2004 M/62 Taiwan Liver cirrhosis, Encephalopathy, Spontaneous bacterial peritonitis Bloodstream infection/CA Amikacin, Aztreonam, Cefotaxime, Cefepime, Chloramphenicol, Ciprofloxacin Flomoxef, Gentamicin, Imipenem, Piperacillin-Tazobactam, Tetracycline, Tobramycin, Co-trimoxazole Ampicillin, Cefazolin, Cefoperazone, Ceftazidime, Ceftriaxone Cefotaxime Complete recovery Han et al., [ 46 ], B. diminuta 2005 Multiple (7 Cases) USA Cancer Bacteraemia, Urinary Tract Infection, Empyema/HA Amikacin, Imipenem and Ticarcillin/clavulanate Ampicillin, Cefepime, Ciprofloxacin Cefepime, Imipenem, Levofloxacin, Meropenem, Nafcillin, Tobramycin, Ticarcillin/ clavulanate, Vancomycin Complete recovery Karadag et al. [ 38 ], B. vesicularis 2005–2011 Multiple (8 cases) Turkey Neonates Septicaemia/HA Amikacin, Imipenem, Aztreonam, Ceftazidime, Piperacillin/tazobactam Ampicillin, Cefotaxime, Ciprofloxacin, Meropenem, 7 Complete recovery, 1 Died Vahid [ 64 ] B. vesicularis 2005 W/36 USA Acute myelogenous leukaemia Bacteraemia Ciprofloxacin, Ticaracillin-Clavulanate Amikacin, Aztreonam, Cefepime, Ceftazidime, Ceftriaxone, Meropenem, Piperacillin/tazobactam Initially: Amikacin, Ampohotericin B, Gancyclovir Vancomycin Died Papaefstathiou et al., [ 65 ], B. vesicularis 2005 F/92 Greece …”
Section: Factors Associated With Infectionmentioning
confidence: 99%